RecBio ^None

Jiangsu Ruike Biotechnology Co., Ltd. (hereinafter referred to as "Ruico Bio" or "Company", stock code: 02179.HK) was established in 2012. It is an innovative vaccine company with independent research and development technology as its core driving force.Create an innovative vaccine covering R & D, production and commercialization.For a long time, the company has always adhered to the mission of "creating first -class vaccine and guarding human health". With a strong R & D engine composed of core technology platforms such as new -type salads, protein engineering, and immunological evaluation, it has a major burden with a strategic focus ..Then, then